The Safety and Maximum Tolerated Dose of Axitinib in Combination With Radiotherapy for HCC
Clinical trial NCT02814461 · COMPLETED
Trial details
- NCT number
- NCT02814461
- Sponsor
- Shin Kong Wu Ho-Su Memorial Hospital
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-11-01
- Primary completion
- 2018-11-01
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.